I WANT TO WELCOME YOU ALL TO TODAY'S WEBINAR. THE NIDA RACIAL EQUITY INITIATIVES WAS FORMED IN JUNE OF 2020 BY DR. NORA VOLKA. AND INCLUDES OVER 80 NIDA STAFF MEMBERS. THE MAIN CATALYST WAS THE UNREST OF VIOLENCE EXPERIENCED BY BLACK AMERICANS. OF COURSE THESE DEEP ROOTED SYSTEMATIC ISSUES WERE MAGNIFIED DURING THE COVID-19 PANDEMIC WHICH SHINED A LIGHT ON THESE PRESSING ISSUES. TO ORGANIZE THE INSTITUTE'S EFFORT TO ADDRESS THE IMPACT OF STRUCTURAL RACISM ON ADDITION SCIENCE. AS PART OF REI NIDA HAS COMMITTED TO INCREASE FUNDING OVER A 10 YEAR PERIOD IN SUPPORT OF REI GOALS MULTIPLE MEETINGS AND LISTENING SESSIONS HAVE BEEN LED BY REI TO BROADLY ENGAGE THE SCIENTIFIC COMMUNITY IN THE INTEREST OF GUIDING REI GOALS. UNDER REI NIDA HAS ISSUED MULTIPLE FUNDING OPPORTUNITIES. DURING 2021 NIDA PLOYED SUPPLEMENTAL AWARDS TO EXHIBITING GRANTS AS WELL AS DIVERSE TEAMS. IN WHICH WE FUNDED OVER 50 GRANTS TO DATE. TODAY'S SESSION WILL OFFER AN OVERVIEW. YOU WILL HAVE AN OPPORTUNITY TO POSE QUESTIONS TO NIDA STAFF ABOUT THE APPLICATION PROCESS, REVIEW AS WELL AS FUNDING OPPORTUNITIES. WE HOPE YOU ARE AS EXCITED AS WE ARE ABOUT THESE OPPORTUNITIES. WE LOOK FORWARD TO GROWING THE RESEARCH PORTFOLIO THAT REFLECTS DIVERSE PERSPECTIVES TOWARD ELIMINATING INEQUITIES AND HEALTH FACED BY RACIAL AND ETHNIC MINORITIES. NOW I WILL INTRODUCE DR. ARIA CRUMP. >>THANK YOU SO MUCH, WILL. I'M AURA CRUMP THANK YOU FOR JOINING TODAY'S WEBINAR. YOU'LL HEAR ABOUT NINE RFAs THAT NIDA HAS PUBLISHED. NOTE THAT WHILE YOU'LL HEAR FROM THE LEAD CONTACTS THESE RESULTED FROM A COLLECTED EFFORT. AT THIS SESSION WELL SRI A BRIEF VIDEO THAT PROVIDES AN OVERVIEW OF THE RFAs. AFTER THE VIDEO DR. PREETHY WILL DISCUSS THE REVIEW PROCESS. AND FOLLOWING HER PRESENTATION WE WILL REVIEW SOME FAQs FOR THE PROGRAMS AND ALSO ADDRESS QUESTIONS THAT YOU HAVE THAT YOU TYPE INTO THE ZOOM Q&A FEATURE. AT THIS TIME AND THROUGHOUT THIS PRESENTATION YOU CAN ADD QUESTIONS TO THE Q&A. WHEN YOU SUBMIT THE QUESTION PLEASE INDICATE WHICH RFA IS THE TOPIC OF YOUR QUESTION. YOU CAN USE THE INITIALS THAT ARE IN RED ON THIS SLIDE AS A SHORTHAND TO INDICATE WHICH RFA. IN A FEW DAYS THE VIDEO WILL BE MADE AVAILABLE THROUGH NIH VIDEO CAST. WE'LL DROP A LINK IN THE CHAT FOR HOW TO ACCESS THIS. ALSO A FREQUENTLY ASKED QUESTIONS DOCUMENT WILL BE POSTED ON THE NIDA REI WEBSITE. SO PLEASE STAY TUNED AND STAND BY FOR THE BRIEF VIDEO. >>HELLO AND WELCOME TO A TECHNICAL ASSISTANCE WEBINAR FOR A NEW FUNDING INITIATIVE FROM NIDA. MY NAME IS VANI PARIYADATH AND I’M CHIEF OF THE BEHAVIORAL AND COGNITIVE NEUROSCIENCE BRANCH WITHIN THE DIVISION OF NEUROSCIENCE AND BEHAVIOR. IN 2020, NIDA ESTABLISHED TH >>THANK YOU. I'M ARIA CRUMP. AND I'M HERE TO TELL YOU TODAY ABOUT THE NIDA RACIAL INITIATIVE FUNDING OPPORTUNITY. WE'RE VERY ENTHUSIASTIC ABOUT THE OPPORTUNITY TO SOLICIT APPLICATIONS TO ADVANCE EQUITY FOR RACIAL AND ETHNIC MINORITY POPULATIONS IN THE U.S. THAT ARE DISPROPORTIONATELY AFFECTED. WE'RE LOOKING FOR INNOVATIVE SOLUTION ORIENTED RESEARCH PROJECTS AND PARTICULARLY INTERESTED IN THOSE THAT INVOLVE COMMUNITY ENGAGEMENT AND BROAD DISSEMINATION OF THE RESEARCH FINDINGS. AND PARTICULARLY APPLICATIONS THAT WILL INCORPORATE DIVERSE PERSPECTIVES. KEEP IN MIND MANY HAVE MULTIPLE RECEIPT DATES. >>HELLO. MY NAME IS SHEBA DUNSTON. I WILL PROVIDE A BRIEF OVERVIEW OF THE HIV RACIAL EQUITY INITIATIVE FUNDING OPPORTUNITY. SO THE PURPOSE OF THIS INITIATIVE IS TO STILL RATE NEW OBSERVATIONAL AND INTERVENTION RESEARCH ON STRUCTURAL FACTORS, ORGANIZATIONAL PRACTICES AND POLICIES AND OTHER SOCIAL AND CULTURAL AND CONTEXTUAL INFLUENCES THAT LEAD TO INEQUITIES AMONG UNDERSERVED POPULATIONS. WE FUNDING TWO MECHANISMS AND WE'RE LOOKING FOR INNOVATIVE RESEARCH TO INFORM EFFORT TO ADDRESS INEQUITIES IN HIV PREVENTION, DIAGNOSIS AND TREAT. -- TREATMENT. SO PROPOSESSED STUDIES CAN BE OBSERVATIONAL OR INTERVENTION STUDIES. STUDIES THAT CAN PROVIDE A DEEP UNDERSTANDING OF HOW FACTORS INTERACT TO PERPETUATE AND AMELIORATE. REGARDING INTERVENTION STUDIES WE'RE LOOKING FOR STUDIES THAT CAN TEST NOVEL STRATEGIES THAT FOCUS ON SOCIAL STRUCTURAL AND POLICY FACTORS. SO THERE ARE MANY TOPICS OF INTEREST THAT CAN INCLUDE SOME I LISTED HERE BUT ARE NOT LIMITED. LOOKING FOR STUDIES THAT CAN EXAMINE RACIAL DISJIM NATION, BIAS, DISCRIMINATION IN EDUCATION, EMPLOYMENT, HOUSING, HEALTH CARE, PATIENT PROVIDER, COMMUNICATION, SERVICES, POLICIES, LAWS AND HOW THEY CONTRIBUTE TO DISPARITIES IN HIV AND SUBSTANCE USE. REGARDING INTERVENTION RESEARCH, RESEARCH THAT CAN TEST OR DEVOTE INTERVENTION OR NEW MODELS OF SERVICE DELIVERY TO ENHANCE CULTURAL COMPETENT TIPS AND INCREASE STATE AND LOCAL PARTNERSHIPS AS WELL AS ELIMINATION BARRIERS TO CARE. >>GOOD AFTERNOON, MY NAME IS KATHY ETZ AND I'M THE DIRECTOR OF THE NATIVE AMERICAN PROGRAM AT NEED A. I'M GOING TO SHARE BREACH POSITION ON THE ANNOUNCEMENTS ADDRESSING RACIAL EQUITY AND SUBSTANCE ABUSE THROUGH COMMUNITY ENGAGED RESEARCH. THE PURPOSE IS TO INVITE APPLICATIONS FOR COMMUNITY ENGAGED RESEARCH THAT WILL HAVE A MAJOR IMPACT IN IDENTIFYING, DEVELOPING, IMPLEMENTING AND/OR TESTING STRATEGIES TO PREVENT, REDUCE OR ELIMINATE RACIAL AND/OR ETHNIC DISPARITIES IN SUBSTANCE ABUSE ADDICTION AND RELATED OUTCOMES. BASIC INFORMATION IS INCLUDED ON THESE SLIDE. WHILE $2 MILLION IS SET ASIDE VARIOUS APPLICATIONS CAN BE CONSIDERED. I WANT TO HIGHLIGHT SOME UNIQUE FEATURES. COMMUNITY ENGAGEMENT IS REQUIRED AND THE COMMUNITY ACADEMIC PARTNERSHIP MUST BE ESTABLISHED PRIOR TO THE APPLICATION. PARTNERS WILL BE ENGAGE EDUCATE IN ALL PHASES OF THE * OF THE PROJECT INCLUDING IDENTIFYING RESEARCH QUESTIONS THAT REFLECT THE EXPERIENCE. THE FIRST YEAR CAN BE SPENT FURTHER DEVELOPING A PROJECT IN THE PHASED APPROACH HOWEVER TAKE CARE TO ENSURING THEM THAT THE PROJECT REMAINS FEASIBLE. NO PRELIMINARY DATE ARE REQUIRED BUT THE WORK SHOULD BE PROMISED ON A STRONG THEORETICAL FOUNDATION AND LODGING. -- LOGIC. * THIS MEANS MOVING BEYOND MEASURING RACE AND ETHNICITY AS DEMOGRAPHIC VARIABLES TO CONCEPTUALIZING TO CAPTURE THE FACTORS THAT ARE THE ROOT CAUSES. FOR EXAMPLE, THIS COULD INCLUDE EXPERIENCES OF RACISM. STRUCTURAL FACTORS AND/OR BARRIERS SHOULD BE CONSIDERED IN THE CONCEPTUAL MODEL. SOCIAL FACTORS DO NOT HAVE TO BE DIRECTLY MEASURED THOUGH THEY CAN BE. CONSIDER HOW STRUCTURAL FACTORS MAY BE THE DRIVERS OF OUTCOMES. AND INCORPORATING THESE FACTORS IN THE RESEARCH AS RELEVANT. 7 IDEOLOGICAL RESEARCH * SHOULD INCLUDE A CLEAR AND SPECIFIC RATIONAL FOR WHY MORE OBSERVATIONAL RESEARCH IS NEEDED. THANK YOU AND GOOD LUCK WITH YOUR APPLICATION. >>THIS AIMS TO SUPPORT STUDIES THAT UNPACK THE COMPLEX EFFECT. THIS RFA EMPLOYS THE BASE AWARD MECHANISM OR THE R61/R33. TOPIC OF INTEREST INCLUDE BUT ARE NOT LIMITED TO DEVELOPMENT AND APPLICATION OF ASSESSMENT TOOLS TOWARD CAPTURING MULTI-DIMENSION, SOCIO ENVIRONMENTAL INFLUENCES THAT MINIMIZE PARTICIPANT BURDEN AND INCREASE INCLUSION OF UNDERSERVED RACIAL AND ETHNIC MINORITY GROUPS. RELEVANCE TO STRUCTURAL RACISM. RELEVANCE TO PREVENTIVE INTEREST VISION. MULTI-DISCIPLINARY TEAMS. MULTI-DIMENSIONAL APPROACH AND COMMUNITY ENGAGED RESEARCH. 7 >>NEXT I'M HERE TO TELL YOU ABOUT NIDA'S RACIAL EQUITY VISIONARY AWARD. THIS PROGRAM IS DESIGNED TO SUPPORT INDEPENDENT INVESTIGATORS WHO WILL CONDUCT HIGHLY INNOVATIVE CLINICAL RESEARCH PROJECT THAT'S CHALLENGE SCIENTIFIC PARADIGMS. AND ALSO LAY GROUNDWORK FOR LARGE SCALE EFFORTS TO IMPACT SUBSTANCE USE RELATED DISPARITIES. THE MECHANISM IS THE DT1. THIS IS A SINGLE INVESTIGATOR AWARD AND CLINICAL TRIALS ARE ALLOWED BUT THEY ARE OPTIONAL. THE BUDGET IS LIMITED TO $700,000 IN DIRECT COST PER YEAR AND A MAX MUCH OF FIVE YEARS. THERE ARE TWO COMPANION FOAs. ONE IS FOR VARIOUS INSTITUTIONS. THE OTHER IS SPECIFICALLY FOR MINORITY SERVING INSTITUTIONS AS DEFINED IN PART 2 SECTION 3 OF THE FOA. MINORITY SERVING INSTITUTION MUST HAVE RECEIVED LESS THAN $25 MILLION OVER THE PRIOR TWO YEARS. THE INVESTIGATORS WHOSE RESEARCH IS HIV FOCUSED RESEARCH SHOULD BE APPLYING UNDER NIDA'S CURRENT AWARD PROGRAM AS OPPOSED TO THE RACIAL EQUITY VISIONARY AWARD. THE INVESTIGATORS FOR RACIAL EQUITY VISIONARY AWARD ARE EXPECT TO BE HEALTH EQUITY, HEALTH DISPARITIES. WITH PRIOR EXPERIENCE COLLABORATING WITH TO CONDUCT RESEARCH WITH U.S. RACIAL AND ETHNIC MINORITY GROUPS. THE APPLICATIONS ARE EXPECTED TO BE HIGHLY INNOVATIVE AND IDEALLY WILL INTERVENE ON SYSTEMIC FACTORS. MUST INCLUDE COLLABORATIONS WITH COMMUNITY MEMBERS AND A UNIQUE APPLICATION. A FIVE PAGES SAY THAT INCLUDES A LETTER OF SUPPORT FROM A COMMUNITY COLLABORATOR AND THREE LETTERS OF REFERENCE. THERE IS AN EXPECTATION THAT DATASETTING AND RESOURCE PLAN BE INCLUDED AND PILOT STUDIES ARE ALLOWED BUT NOT REQUIRED. PLEASE KEEP IN MIND THAT NO DEPENDENCIES ARE ALLOWED. >>HELLO. MY NAME IS KEISHER. HIGHSMITH. TODAY I WILL BE PROVIDING A BRIEF OVERVIEW OF THE -- TO SUPPORT RESEARCH ON RACIAL EQUITY AND STRATEGIES TO REDUCE SUBSTANCE USE DISPARITIES. THE FUNDING MECHANISM FOR THE RFA IS A U2 4 OR A COOPERATIVE AGREEMENT. DIFFERENT FROM A STANDARD FRAME. NIDA PROJECT STAFF SPECIFICALLY THE SCIENCE OFFICER WORKS CLOSELY WITH THE INVESTIGATOR TEAM AND COORDINATION AND COOPERATION AND PARTICIPATION IN THE ASPECT OF THE REI PROJECT. THE PROPOSED BUDGET MAY NOT EXCEED $500,000 IN DIRECT COST PER YEAR AND THE PROJECT PERIOD MAY NOT EXCEED FIVE YEARS. KEY ITEMS YOU WANT TO PAY SPECIAL ATTENTION TO -- WE ARE LOOKING FOR DIVERSE INVESTIGATOR TEAMS WITH SPECIFIC SKILLS AND EXPERTISE. SOME ARE LISTED ON THE SLIDE. YOU MUST HAVE A PLAN -- DIVERSE PERSPECTIVE. YOUR APPLICATION WILL NOT BE REVIEWED WITHOUT THIS PLAN. THERE WILL BE ADVISORY GROUPS. SPECIFICALLY A STEERING COMMITTEE AND EXPERT PANEL. THE SCHEDULE IS EXPECT TO INCLUDE IN THE BUDGET FUNDS TO SUPPORT THE SALARY FOR THE STEERING COMMITTEE CHAIR AND HONORARIUM FOR THE MEMBERS OF THE EXPERT PANEL. KEY DATES TO MARK OTHER YOUR CALENDARS ARE LISTED AT THE BOTTOM OF THE SLIDE. I WISH I ALL THE BEST WITH YOUR SUBMISSION. THANK YOU. >>AS A REMINDER FOR RFADA -- COORDINATION CENTER -- THERE IS A SINGLE SUBMISSION DATE NOVEMBER 15,2022. FOR ALL OF THE OTHER RFAs THE DATES ARE NOVEMBER 14, 2022, TO 223 AND 2024. THE WEBSITE LINK IS PROVIDED HERE. THANK YOU FOR YOUR INTEREST IN THESE NIDA REI FUNDING OPPORTUNITY. PLEASE DO NOT HESITATE TO REACH OUT TO ANY OF THE CONTACTS IF YOU HAVE QUESTIONS. WE LOOK FORWARD TO HEARING FROM YOU. >>GOOD AFTERNOON. MY NAME IS TREES.Y MIRE. AND I WILL BE PROVIDING A BRIEF OVERVIEW OF THE PEER REVIEW PROCESS AND THE RECRUIT CRITERIA FOR THESE FUNDING OPPORTUNITY ANNOUNCEMENTS. SO WHEN THE APPLICATIONS ARE RECEIVED NIDA STAFF WILL CARRY OUT THE ADMINISTRATIVE REVIEW OF THE APPLICATIONS SO ALL OF THE SUBMISSIONS WILL BE EVALUATED BY NIDA STAFF FOR COMPLETENESS AND COMPLIANCE AS WELL AS ADHERENCE TO -- GUIDELINES. PLEASE BE SURE TO MAKE SURE THAT YOUR APPLICATIONS CONFORM TO THE REQUIREMENTS. IF YOUR APPLICATION INCLUDES A CLINICAL TRIAL MAKE SURE TO COMPLY WITH REQUIREMENTS FOR THE NIH DEFINED CLINICAL TRIALS AND YOU CAN CHECK TO DETERMINE IF YOUR STUDY IS AN NIH DEFINED CLINICAL TRIAL. IF APPLICABLE PLEASE USE A SINGLE IRB AS REQUIRED BY THE POLICY AND INCLUDE ONLY ALLOWABLE APPENDIX MATERIALS AS PER THE APPLICATION INSTRUCTIONS. BE SURE TO READ THE INCLUSION OF SPECIAL CONSIDERATIONS. AND INCOMPLETE APPLICATIONS THAT ARE NOT ADHERING TO THE FOUR REQUIREMENTS MAY BE RETURNED WITHOUT REVIEW. WITH REGARDS TO THE PEER REVIEW OF THESE APPLICATIONS THEY WILL BE CONDUCTED AT NE NIDA. THE OFFICER MANAGING THE REVIEW WILL CREATE SPECIAL EMPHASIS PANELS BASED ON THE AREAS OF SCIENCE DESCRIBED IN THE APPLICATION. CONFLICTS OF INTEREST ARE MANAGED FOR ALL PANEL REVIEW MEMBERS SO PLEASE KEEP IN MIND THAT NIDA TAKES CONFLICTS OF INTEREST VERY SERIOUSLY AND WILL MAKE SURE THAT ALL CONFLICTS OF INTERESTS ARE ADDRESSED PRIOR TO THE MEETING. AT LEAST THREE REVIEWERS WILL BE ASSIGNED TO EVALUATE EACH APPLICATION AND THE REVIEW PANEL WILL RECEIVE GUIDANCE FROM NIDA STAFF ON HOW TO EVALUATE THE APPLICATIONS. PANEL MEMBERS WILL HAVE AT LEAST 30 DAYS TO EVALUATE THE APPLICATIONS. AND THE MEETING ROSTER WILL BE PUBLICLY AVAILABLE 30 DAYS PRIOR TO THE MEETING. SO THIS SLIDE IS A BRIEF OVERVIEW OF THE REVIEW CRITERIA. THESE APPLICATIONS WILL BE EVALUATED FOR THEIR TECHNICAL AND SCIENTIFIC MERIT AND THE LIKELIHOOD OF THE APPLICATIONS TO -- ON THE FIELDS INVOLVED AND THE EVALUATION WILL TAKE INTO ACCOUNT THE FIVE CORE REVIEW CRITERIA YOU'RE FAMILIAR WITH. WHERE APPLICABLE THERE ARE ADDITIONAL REVIEW CRITERIA THAT IMPACTS THE OVER-ALL SCORE. THESE ARE STUDY TIME LINE IF IT'S A CLINICAL TRIAL APPLICATION. IF IT'S A HUMAN SUGGEST APPLICATION IT'S PROTECTION OF HUMAN SUBJECTS. *. IN ADDITION THERE ARE ADDITIONAL REVIEW CONSIDERATIONS THAT DO NOT IMPACT OVER-ALL IMPACT SCORE AND THEY MAY OR MAY NOT BE RELEVANT. THESE INCLUDE AUTHENTICATION OF KEY BIOLOGICAL RESOURCES AS WELL AS THE BUDGET. SO EACH OF THE REIRFAs INCLUDE SPECIFIC REQUIREMENTS SO MAKE SURE YOU'RE FAMILIAR WITH THESE REQUIREMENTS. THE CLINICAL TRIALS, THE PLAN FOR ENHANCING DIVERSE PERSPECTIVES AND REVIEW THE SECTION FIVE OF THE FUNDING OPPORTUNITY ANNOUNCEMENT FOR THE FOA SPECIFIC REVIEW CRITERIA. AND REMEMBER THAT THESE ARE IN ADDITION TO THE STANDARD REQUIREMENTS. AS PART OF THE SCIENTIFIC PEER REVIEW ALL APPLICATIONS WILL RECEIVE A WRITTEN CRITIQUE. APPLICATIONS MAY UNDERGO A SELECTION PROCESS IN WHICH ONLY THE MOST HER TONE YOUR * APPLICATIONS -- AND THESE ARE GENERALLY THE TOP HALF OF THE APPLICATIONS UNDER REVIEW WILL RECEIVE AN ASSIGNED OVER-ALL IMPACT SCORE. BUT ALL WILL RECEIVE A CRITIQUE THAT IS A SUMMARY STATEMENT WHICH WILL BE AVAILABLE WITHIN FOUR TO SIX WEEKS AFTER THE COMPLETION OF THE MEETING. THANK YOU. >>CAN I HAVE ALL OF THE PANELISTS TO TURN YOUR CAMERAS ON. GREAT. SO, ITS NOW YOUR OPPORTUNITY TO HAVE YOUR QUESTIONS ANSWERED. IF YOU HAVE NOT ALREADY PLEASE GO AHEAD AND ENTER QUESTIONS INTO THE Q&A. YOU'VE ALREADY MET DR. BREATHY NAYAR. DR.*. WHY DON'T WE GO AHEAD AND I'LL TURN IT OVER TO DR. 'S ROMBERG AND HIGHSMITH WHO WILL MODERATE THE Q&A SESSION >>THANK YOU. AND HELLO AGAIN. THANK YOU FOR THE GREAT VIDEOS AND THE QUESTIONS. WE HAVE A COUPLE OF QUESTIONS. THE FIRST IS TO YOU DR. CRUMP. SHOULD AT LEAST ONE LETTER OF REFERENCE COME FROM A COMMUNITY LEADER/PARTNER OR SHOULD ALL THREE BE ACADEMIC REFERENCES? >>THAT IS A GREAT QUESTION. THE NICE THING ABOUT THE DP1 IS THAT YOU -- ARE ABLE TO PAINT THE PICTURE IF YOU WILL THAT YOU WOULD LIKE TO PAINT FOR THE REVIEWERS. SO THERE IS NO REQUIREMENT ABOUT WHO THE LETTERS OF REFERENCE SHOULD COME FROM. THERE IS NO EXPECTATION. BUT I WOULD STRONGLY RECOMMEND THAT YOU THINK ABOUT HOW TO BEST MEET THE CRITERIA OF THE DP1 AWARD. SO THINK ABOUT WHICH INDIVIDUALS WOULD BEST REFLECT YOUR ENGAGEMENT. WITH THE COMMUNITY. 8 WOULD BEST REFLECT YOUR PROMISE FOR CREATING HIGHLY INNOVATIVE GAME CHANGING PARADIGM SHIFTING SCIENCE TO ADDRESS RACIAL EQUITY. 7 AND SO I'LL LEAVE IT AT THAT. I'M HAPPY TO DISCUSS THIS FURTHER WITH APPLICANTS IF YOU REACH OUT TO ME. THIS IS SOMETHING WHERE YOU'RE ABLE TO TELL YOUR OWN STORY. >>AND THERE IS ONE FOLLOW-UP QUESTION. COUNTY LETTER OF SUPPORT COME FROM A COMMUNITY RESEARCH TEAM/BOARD? AND LETTER OF SUPPORT FROM MULTIPLE PEOPLE? >>THAT IS A GREAT QUESTION. SO THE LETTERS FIRST AFTER THE DP1 REQUIRES THREE LETTERS OF RECOMMENDATION AND A LETTER OF SUPPORT. THIS IS AGAIN IS A VERY UNIQUE MECHANISM. THERE IS ONLY FIVE PAGES THAT IS ALLOWED TO THE TEXT. SO WE REALLY ARE ASKING YOU TO PACK A LOT OF INFORMATION INTO A LITTLE BIT OF REAL ESTATE IN TERMS OF PAGES. SO WE ONLY WOULD LIKE TO SEE ONE LETTER OF SUPPORT. THAT IS WHAT WE REQUESTED SO, THAT IS WHAT WE WOULD LIKE TO SEE. AND THREE LETTERS OF REFERENCE SO YOU CAN HAVE THAT LETTER OF SUPPORT COME FROM I STRONGLY RECOMMEND THAT IT COME FROM THE GROUP OR GROUPS WHO WILL BE A PART OF THE COLLABORATION. BECAUSE THAT REALLY SHOWS THAT YOU HAVE ESTABLISHED THAT CONTACT. AND I'LL JUST LEAVE THAT AT THAT. >>OKAY. I SEE THERE IS ONE MORE QUESTION. AND IT'S AROUND THE REVIEW PROCESS. IS THE REVIEW PROCESS EXPECT SPRING 2023? >>I'M GOING TO TURN THAT OVER TO DR. NAYER. >>SORRY. COULD YOU REPEAT THE QUESTION, PLEASE. >>SURE IS THE REVIEW PROCESS FOR THE DP1 EXPECT SPRING 2023? >>I AM NOT QUITE SURE I UNDERSTAND STOOD THE QUESTION. >>SO WHEN WILL THE REVIEW PROCESS TAKE PLACE FOR THE DP1? >>OKAY. SO GENERALLY THE REVIEW PROCESS TAKES PLACE WITHIN 8-12 WEEKS OF THE RECEIPT OF APPLICATIONS. THAT IS WHEN THE REVIEW PROCESS -- AND IN GENERAL THE SUMMARY STATEMENTS ARE RELEASED ABOUT 30 DAYS BEFORE COUNCIL SO, THAT IS WHEN THE SUMMARY STATEMENTS WOULD ALSO BE AVAILABLE. >>AND I'LL JUMP IN AND SAY THE DP1 REVIEW IS QUITE UNIQUE FROM THE OTHER STANDARD NIH AWARDS. AT LEAST FOR NEED A. THE WAY NEED AS STRUCTURING * THIS IS WE EXPECT THERE WILL BE AN INTERVIEW PORTION AS WELL AS FOR THOSE WHO ARE HAVE THE HIGHEST PROMISE THE HIGHEST PRIORITY THERE WILL BE AN INTERVIEW PROCESS FOR THIS PARTICULAR MECHANISM. SO THAT GIVES YOU A CHANCE TO SPEAK DIRECTLY TO WHAT THE PROMISE IS OF YOUR WORK. >>THAT IS CORRECT. SO THERE IS AN INTERVIEW PROCESS WHICH MAKES IT QUITE UNIQUE AS COMPARED TO THE NORMAL RO1 OR OTHER GRANT APPLICATION THAT'S YOU'RE FAMILIAR WITH YOU. -WITH. >>OKAY. AND NOW WE HAVE A QUESTION FOR DR. AKLIN. THIS QUESTION -- I THINK THE FUNDING MECHANISMS HERE ARE VERY IMPORTANT. HOWEVER, IF THE NIH TRULY WANTS TO SUPPORT RACIAL EQUITY MORE NEEDS TO BE DONE. I WOULD LIKE TO HEAR ABOUT HOW THIS IS PART OF A BROADER INITIATIVE TO SUPPORT THE LINE. RAISING SALARY CAP, INCREASING CHILD CARE SUPPORT AND INCREASING T32 BUDGETS. IT'S UN10ABLE. *. SO WOULD YOU LIKE TO LIKE TO ADDRESS SOME OF THE ISSUES THAT THIS PARTICIPANT RAISES? >>THANKS, DR. ROMBERG. THAT'S AN IMPORTANT QUESTION. THAT AUDIENCE MEMBER BROUGHT UP IMPORTANT SYSTEMIC POINTS THAT WE ARE CONSIDERING STRONGLY. WE HAVE AS MANY HAVE HEARD A NIDA RACIAL EQUITY INITIATIVE ACTION PLAN. PART OF THAT HAS REALLY TRIED TO ENGAGE THE COMMUNITY TO THINK ABOUT HOW CAN WE MOVE SUGGESTIONS LIKE THAT FORWARD IN A WAY THAT WILL CHANGE POLICIES IN A WAY THAT WILL MOVE RECOMMENDATIONS FORWARD. SO OUR ACTION PLAN IS CURRENTLY UNDERWAY. THE ANALYSIS HAVE CLOSED BUT WE'RE NOW IN THE PROCESS OF ANALYZING THOSE DATA AND A REPORT WILL BE AVAILABLE IN THE MONTH OF OCTOBER. SO WE WILL HAVE ONE OF THOSE KEY RECOMMENDATIONS ARE EXACTLY WHAT THIS WRITER HAS POINTED OUT. SO THANK YOU VERY MUCH FOR THAT QUESTION. >>THANK YOU. AND SO NOW DR. ET WERE, CAN YOU TALK ABOUT WHAT LIMITED COMPETITION MEANS? >>SURE. THANK YOU FOR THAT QUESTION. SO LIMITED COMPETITION MEANS THAT ONLY CERTAIN ELIGIBLES ARE ELIGIBLE TO APPLY FOR THE FUNDING OPPORTUNITY ANNOUNCEMENT. AND THIS CASE THE LIMITATION IS FOR THE MSI APPLICATION. THE MINORITY SERVING INSTITUTION APPLICATIONS. YOU NEED TO BE PART OF AN INSTITUTION OR UNIVERSITY THAT MEETS WHAT IS SPELLED OUT IN THE FUNDING OPPORTUNITY ANNOUNCEMENT. WE'LL TALK MORE ABOUT SPECIFICALLY WHAT THOSE CRUISE TIER YA ARE FOR THAT LIMITED COMPETITION. >>OKAY. AND THIS QUESTION IS FOR DR. CRUMP. HOW CAN I BE CERTAIN THAT MY APPLICATION IS RESPONSIVE TO THE RFAEST TESTS? >>THAT'S AN IMPORTANT QUESTION. THE MOST CRITICAL THING THAT YOU CAN DO IS READ THE FUNDING OPPORTUNITY ANNOUNCEMENT VERY CAREFULLY AND ATTEND TO THE FIRST OFF THE CONTENT THE SUBSTANTIVE CONTEMPT. PROVIDING THE TYPE OF RESEARCH THAT IS BEING CALLED FOR. THROUGH THE RFA. BUT THEN BEYOND THAT PAY ATTENTION TO PART ONE SECTION ONE. PART ONE SECTION FOUR WHERE THEY ARE PROVIDING DETAILS ABOUT WHAT NEED TO DO TO HAVE A COMPLETE APPLICATION. SO YOU WANT TO MAKE SURE THAT IF THERE IS A PEDP OR PLAN FOR ENHANCING DIVERSE PERSPECTIVES THAT IS REQUIRED AS A SEPARATE ATTACHMENT YOU WANT TO MAKE SURE YOU COMPLETE THAT AND ATTACH IT AS DIRECTED. WITH REGARD TO ELIGIBILITY WE JUST HEARD A QUESTION ABOUT LIMITED COMPETITION. IF YOU APPLY UNDER ONE OF THE MINORITY SERVING INSTITUTIONS FOAs THAT YOU FULLY ADDRESS AND MEET THE REQUIREMENTS IN SECTION THREE OF PART TWO SECTION THREE OF THE FUNDING OPPORTUNITY ANNOUNCEMENT. THE OTHER THING IS MAKE SURE THAT YOU DON'T INCLUDE THINGS THAT ARE NOT ALLOWED. IT MAY SEEM UNFORTUNATE FOR AN APPLICATION TO BE CALLED NONRESPONSIVE BECAUSE IT HAS EXTRA INFORMATION. BUT IN FACT IT CAN BE SO IF THERE ARE UNALLOWED APPENDICES YOUR APPLICATION CAN BE DEEMED NONRESPONSIVE. SO THE OTHER THING IS IF YOU HAVE ANY QUESTIONS ABOUT RESPONSIVENESS PLEASE REACH OUT TO THE PROGRAM CONTACT. AND EVEN IF YOU DON'T IF YOU HAVE QUESTIONS IN GENERAL ABOUT THE FIT FOR NIDA'S PRIORITIES ALSO PLEASE REACH OUT TO THE PROGRAM CONTACT AND THE CONTACTS ARE LISTED IN SECTION SEVEN PART TWO SECTION SEVEN. YES. >>SO OUR NEXT QUESTION IS FOR DR. DUNSTON. I'M THINKING ABOUT DOING AN OBSERVATIONAL STUDY FOR -- FOA-023. HOW IMPORTANT IS IT FOR BOTH SUBSTANCE USE AND HIV TO BE OUTCOMES IN THE STUDY DESIGN. THE CONCEPTUAL MODEL USED SUBSTANCE USE AS A MEDIATOR. >>THANK YOU FOR THAT QUESTION. SO I WOULD SAY -- FIRST YOU HAVE TO REMEMBER THAT THESE INITIATIVES ARE SPECIFICALLY LOOKING AT INEQUITIES WITH REGARD TO SUBSTANCE USE AND SO THE HIV INITIATIVE SPECIFICALLY IS LOOKING AT THE INTERSECTION OF SUBSTANCE USE AND HIV AND SO WHAT WE WANT TO SEE IS RESEARCH THAT CAN IMPACT THE SUBSTANCE USE AND HIV FIELD OVER-ALL. SO WE'RE LOOKING FOR OUTCOMES AND IMPACT. IT WILL BE OKAY IF YOU HAVE SUBSTANCE USE AS A MEDIATOR BUT WHAT WE WANT TO SEE IS RESEARCH THAT CAN PUSH THE FIELD TO REALLY UNDERSTAND HOW SUBSTANCE USE CAN IMPACT HIV AND THE INTERSECTION OF BOTH OF THOSE IMPACT DISPARITIES. IT'S MORE IMPORTANT THAT HIV AND SUBSTANCE USE ARE -- HAVE SOME KIND OF OUTCOMES. FOR SUBSTANCE USE AS WELL AS HIV. AND THAT NEEDS TO BE SHOWN IN YOUR APPLICATION ABOUT HOW THIS CAN IMPACT THE FIELD FOR SUBSTANCE USE AS WELL AS HIV. AND IF YOU HAVE ANY MORE SPECIFIC QUESTION I'M THE CONTACT. SO FEEL FREE TO REACH OUT TO ME IF I DIDN'T FULLY ANSWER YOUR QUESTION. >>THERE IS ANOTHER QUESTION AND IT'S A BROAD QUESTION. FOR PERHAPS ALL OF THEM. WHAT IF YOU HAVE NO ACKNOWLEDGE OR UNIVERSITY TO PARTNER WITH? SHOULD YOU STILL APPLY? ALSO ARE THESE FOR PROFIT COMPANIES ONLY? >>* >>THIS IS KATHY. I'LL TAKE A FIRST CRACK AT IT. THE FIRST THING IS I WOULD ENCOURAGE YOU IF THERE IS A SPECIFIC FOA THAT YOU'RE INTERESTED IN I WOULD ENCOURAGE YOU TO REACH OUT DIRECTLY TO ONE OF US AND WE CAN TALK TO YOU ABOUT YOUR SPECIFIC SITUATION AND WHAT MIGHT DO. SO TYPICALLY THE NIH SUPPORTS INSTITUTION AND ORGANIZATIONS THAT ARE FOCUSED ON RESEARCH. OSH THOSE ARE NOT FOR PROFIT COMPANIES. AND BUT CERTAINLY A COMMUNITY-BASED ORGANIZATION COULD ALSO DO RESEARCH. THERE ARE CERTAIN QUALIFICATION THAT'S YOU NEED TO HAVE CERTAIN RELATIONSHIPS WITH THE FEDERAL GOVERNMENT THAT YOU NEED TO HAVE SET UP. SO THERE IS QUITE A LOT OF NUANCE. I WOULD CUT THAT YOU REACH OUT TO ONE OF US DIRECTLY. BUT CERTAINLY WE WANT TO ENCOURENCOURAGE ANYBODY. AND THERE IS OPPORTUNITIES TO PARTNER WITH A COLLEGE OR UNIVERSITY AS A COMMUNITY-BASED ORGANIZATION TO WORK TOGETHER TO CONDUCT THE SCIENCE. >>SO OUR NEXT QUESTION IS ABOUT MEMBERS OF THE REVIEW PANEL. SO PERHAPS DR. YAYAR. THE QUESTION IS FOR THESE RACIAL EQUITY INITIATIVE RELATED RFAs. * IS NIH CONSIDERING INCLUSION OF DISADVANTAGED COMMUNITY MEMBERS TO BE PART OF THE SCIENTIFIC REVIEW COMMITTEE. IT'S IMPORTANT TO ASSESS THE STRENGTH OF THE APPLICATIONS FROM THE PERSPECTIVE OF THE TARGETED COMMUNITY. >>THAT'S AN EXCELLENT QUESTION. ACTUALLY AT THIS TIME WE DO NOT HAVE PLANS FOR COMMUNITY MEMBERS TO BE INVOLVED IN THE REVIEW PANEL. BUT AS I SAID EARLIER AND AS PART OF MY BRIEF OVERVIEW AS THE APPLICATIONS COME IN NIDA PEER REVIEW STAFF WILL BE REVIEWING THE APPLICATIONS FOR THE SCIENTIFIC CONTENT AND WHAT IS COVERED AND BASED ON THAT THEY WILL ASSEMBLE AN EXPERT REVIEW PANEL THAT COVERS ALL OF THE SCIENCE. SO THE SHORT ANSWER IS AT THIS TIME WE DO NOT HAVE UNLIKE THE -- MECHANISM WE DO NOT HAVE COMMUNITY MEMBERS AS PARTICIPANTS IN THE REVIEW PANEL. IT'S MORE OF EXPERTS IN THE FIELD OF REI. >>THANK YOU FOR YOUR RESPONSE. THIS NEXT QUESTION IS FOR THE RACIAL EQUITY VISIONARY AWARD PROGRAM. THE DP1s. IS THERE ANY INTEREST IN MONKEY POX IN PREVENTION THROUGH VACCINES THAT COULD ALSO APPLY TO OTHER PREVENTIONABLE DISEASES. >>THAT IS A GREAT QUESTION. THE SHORT ANSWER TO THAT IS THE SCIENCE HAS TO ALIGN WITH NIDA'S PRIMARY MISSION. AND SO IF THE IDEA IS THAT THIS IS LOOKING AT MONKEY POX IN THE CONTEXT OF PERSONS WHO USE SUBSTANCES OR LOOKING IN SOME WITH A LOOKING AT DISADVANTAGED OR DISPARITIES -- IT'S POSSIBLE. I WOULD STRONGLY RECOMMEND THAT YOU SPEAK WITH PROGRAM CONTACTS TO DISCUSS THAT PARTICULAR AREA SPECIFICALLY. I CAN TELL YOU THAT THE ONE THING THAT IS A LITTLE BIT CHALLENGING WHEN A TOPIC IS NOT CLOSELY ALIGNED WITH NIDA'S MISSION IS THAT IF IT DOES GET A STRONG PRIORITY SCORE THERE MAY BE OTHER PROJECTS THAT HAVE SIMILARLY STRONG SCORES THAT MIGHT BE A HIGHER PRIORITY. SO, THAT IS THE TRIC. IS * THE SHORT ANSWER IS POSSIBLY TALK TO PROGRAM AND JUST BE AWARE THAT IT MAY NOT BE THE HIGHEST PRIORITY. >>OKAY. OUR NEXT QUESTION IS FOR DR. PARIYADATH. APPLICANTS INCLUDE A PLAN FOR IN OR REDUCING THE PEDP. >>THANK YOU, ALEXA. THE PEDP -- IT'S A REQUIREMENT IN SOME NIH APPLICATIONS THAT IS STILL FAIRLY NEW. IT'S INTENDED TO BE A SUMMARY OF STRATEGIES TO ADVANCE THE PROPOSED PROJECT TO INCLUSIVITY. WE'LL PUT A LINK IN THE CHAT WHERE YOU CAN FIND MORE INFORMATION ON KEY ELEMENTS. AND ALSO SOME EXAMPLES OF VARIOUS STRATEGIES. NOW THE CONTENTS WILL DEPEND ON THE NATURE OF THE PROPOSED RESEARCH. SO FOR STUDIES REQUIRED TO BE COMMUNITY ENGAGED BY THE A ANNOUNCEMENTS YOU SHOULD PROVIDE ADDITIONAL DETAILS TO ENHANCE DIVERSE PERSPECTIVES. >>THANKS, ALEXA. >>LOOKING TO SEE IF THERE ARE ANY OTHER QUESTIONS IN THE Q&A. AND I DO WANT TO ENCOURAGE EVERYONE TO SUBMIT YOUR QUESTIONS IN Q&A AS WE MOVE FORWARD AND THANK YOU TO THE PANELISTS FOR BEING VERY RESPONSIVE AND ALSO IN THE CHAT BEING RESPONSIVE IN THE CHAT AS WELL TO QUESTIONS COMING IN. DO YOU HAVE A QUESTION? >>TO THE NEXT QUESTION IS FOR DR. ETZ. SEVERAL DO NOT REQUIRE PRELIMINARY DATA. IF I HAVE PRELIMINARY DATA AM I ALLOWED TO INCLUDE IT? >>SO YES. I THINK THE FOA's CLEARLY STATE THAT YOU'RE ALLOWED TO SUBMIT PRELIMINARY DATA. AND THAT DATA CAN BE FROM THE COMMUNITY THAT YOU'RE WORKING WITH OR YOU COULD USE DATA FROM ANOTHER COMMUNITY OR ANOTHER STUDY. HOWEVER, AS WE'RE HOPING FOR SOME VIEWLY INNOVATIVE PROJECTS HERE THAT ARE WORKING WITH COMMUNITY PARTNERS -- PRELIMINARY DATA MAY NOT ALWAYS BE AVAILABLE. SO WHILE THE FOA CLEARLY STATES THAT PRELIMINARY DATA ARE NOT REQUIRED AND THAT THE STUDY CAN BE FOUNDED ON LOGIC AND LITERATURE I WOULD SUGGEST THAT PEOPLE IN THEIR TEXT REMIND REVIEWERS THAT THE PRELIMINARY DATA ARE NOT REQUIRED AS PART OF THE FOA. >>THANK YOU, DR. ETZ FOR THAT RESPONSE. >>I HAVE A QUESTION FOR DR. ROMBERG. THREE ANNOUNCEMENTS FOR RESEARCH AT MINORITY SERVING INSTITUTIONS. HOW CAN I TELL IF AN INSTITUTION IS ELIGIBLE >>SURE. THANK YOU FOR THE QUESTION. AND THIS IS ABOUT LIMITED COMPETITION AS WELL. SO THESE THREE FOAs -- WHICH ARE LIMITED TO APPLICATIONS FROM MINORITY SERVING INSTITUTIONS. SO APPLICANTS INTERESTED IN APPLYING UNDER THESE THREE LIMITED COMPETITION FOAs SHOULD CAREFULLY REVIEW THE WAY THAT MINORITY SERVINGS INSTITUTIONS IS DEFINED IN SECTION 3 OF THE FOA. THE DEFINITION OF MINORITY SERVING INSTITUTIONS. AND THEY SHOULD INCLUDE IN THEIR APPLICATION THE A ATTACHMENT CALLED INSTITUTIONAL INFORMATION WITH SUPPORTING EVIDENCE THAT THEIR INSTITUTION MEETS THE DEFINITION IN THE FUNDING OPPORTUNITY ANNOUNCEMENT. IN ADDITION TO BEING A MINORITY SERVING INSTITUTION APPLICANTS MUST ALSO MEET TWO ADDITIONAL CRITERIA. ONE IS THAT THE GRANT GRADUATE DEGREES IN THE BIOMEDICAL SCIENCES AND THAT THE INSTITUTION MUST HAVE RECEIVED LESS THAN $25 MILLION TOTAL FROM NIH RESEARCH PROJECT GRANTS IN EACH OF THE LAST TWO FISCAL YEARS. SO THE AMOUNT OF FUNDING CAN BE FOUND THROUGH A SEARCH ON NIH REPORTER AND INSTRUCTIONS WILL BE POSTED IN THE FAQs FOR THESE FOAs ON-LINE. >>THANK YOU, DR. ROMBERG FOR THAT RESPONSE. DR. NAYAR WE HAVE A FOLLOW-UP QUESTION ABOUT REVIEWER SELECTION. HOW WILL REVIEWERS BE SELECTED? >>GREAT QUESTION AND PERHAPS MY PREVIOUS ANSWER WAS NOT CLEAR ENOUGH. SO AS PART OF THE REVIEW WE ALSO REVIEW STAFF -- WILL TAKE A DEEP DIVE INTO THE APPLICAT APPEAR R- APPLICATION . SO THIS IS DONE AFTER THE APPLICATIONS COME IN BECAUSE WE HAVE NO IDEA WHAT IS THE SCOPE OF THE APPLICATIONS THAT ARE COMING IN AND ONCE WE'VE DONE THAT WE IDENTIFY EXPERTS IN THE FIELD WITHIN THOSE SCIENTIFIC CONTENT AREAS THAT ARE IDENTIFIED AND RECRUIT THEM. SO THAT WE MAKE SURE WE HAVE A PANEL THAT COMPARES AND ENCOMPASSES THE BREADTH. THAT ENSURES THAT EACH APPLICATION RECEIVES A FAIR AND EXPERT REVIEW. >>FANTASTIC. THANK YOU. SO THIS QUESTION IS FOR DR. CRUMP AND DR. ETZ. WHAT WAS THE RATIONAL FOR LIMITING MSI ELIGIBILITY IN THE PAST TWO YEARS AND HOW FAR WAS THE $25 MILLION THRESHOLD DETERMINED? >>SO I'LL TAKE A STAB AT THAT. THERE IS A VERY SERIOUS DISPARITY BETWEEN INSTITUTIONS THAT HAVE A LARGE ENDOWMENT, LARGE RESOURCES ARE HIGHLY RESOURCED AND INSTITUTIONS THAT ARE SMALLER INSTITUTIONS MANY OF WHICH ARE MINORITY SERVING INSTITUTIONS. BUT IT'S IMPORTANT TO UNDERSTAND THAT THERE IS NOT ONE DEFINITION FOR WHAT A MINORITY SERVING INSTITUTION IS. AND WE WERE HOPING THROUGH THIS PARTICULAR OR THESE THREE ANNOUNCEMENTS THAT ARE SPECIFICALLY FOR MINORITY SERVING INSTITUTIONS WE WERE HOPING TO LIFT THE FUNDING PROFILE FOR OR AT LEAST PROVIDE ADDITIONAL OPPORTUNITIES I SHOULD SAY FOR INSTITUTIONS THAT ARE LESS RESOURCED. AND SO THE 25 -- THE $25 MILLION IS A BENCHMARK THAT WE BORROWED FROM ANOTHER NIH ANNOUNCEMENT WHERE THEY HAD ASSESSED WHAT WAS A GOOD MARKER AND WE DECIDED THAT WE THOUGHT THAT WAS REASONABLE AND WENT ALONG WITH THAT. AND IT'S ALSO IMPORTANT TO KEEP IN MIND THAT FOR ALL OF THE APPLICATIONS -- THE FUNDING OPPORTUNITY ANNOUNCEMENTS THAT ARE MINORITY SERVING INSTITUTIONS SPECIFIC THERE IS AN OPTION FOR OTHER INSTITUTIONS THAT DON'T MEET THOSE CRITERIA TO APPLY. SO WE JUST REALLY WANTED TO MAKE SURE THAT INSTITUTIONS THAT HAVE BEEN DISADVANTAGED PREVIOUSLY THROUGH THE SELECTION PROCESS HAD AN OPPORTUNITY TO BE RECOGNIZED SEPARATELY. >>AND I THINK ARIA THAT WAS A FANTASTIC ANSWER. I GUESS I WOULD JUST ADD WHEN WE LOOK AT SOME OF THE MSI INSTITUTIONS AND ARIA BASICALLY SAID THIS BUT BEYOND DISADVANTAGED IT'S -- WE SEE THEY ARE UNDER FUNDED IN TERMS OF NIH FUNDING AND CREATING THAT OPPORTUNITY AND PATHWAY PARTICULARLY FOR MSIs THAT ARE FOCUSED ON SOME OF THESE HEALTH DISPARITY ISSUES. >>OKAY. IT LOOKS LIKE WE'RE WAITING FOR MORE QUESTIONS AND ANSWERS. WE'RE WAITING FOR MORE QUESTIONS TO COME IN AND HOPEFULLY ANSWERS TO FOLLOW. BUT WHILE WE'RE WAITING I DON'T KNOW IF ANY OF THE PANELISTS HAVE ANY REMARKS THAT YOU WANT TO SHARE AS OUR PARTICIPANTS ARE THINKING OF QUESTIONS OR COMMENTS TO PROVIDE. >>SO THERE IS ONE COMMENT I CAN MAKE AND THAT IS HAVING BEEN AT THE NIH FOR 22 YEARS I THINK IT'S REALLY EXCITING TO SEE THIS SUITE OF FUNDING OPPORTUNITY ANNOUNCEMENTS. PARTICULARLY THE EMPHASIS ON COMMUNITY ENGAGEMENT AND ENSU ENSURING THAT THESE ARE REAL SOLUTIONS THAT MAKE SENSE FOR PEOPLE OUT IN THE COMMUNITY. SO I HOPE THAT THOSE WHO ARE VIEWING AND THOSE WHO ARE CONSIDERING APPLYING ARE ALSO EXCITED ABOUT THAT. THIS IS A BIT OF A SEA CHANGE. THE FOCUS ON STRUCTURAL FACTORS AND THE ENCOURAGEMENT FOR CONCEPTUALIZING RACE ANDETH NEWS KNEE -- * OUR TEAM IS EXTREMELY ENTHUSIASTIC ABOUT THIS STE. OF FOAs AND WE'RE HOPING THAT THE FIELD WILL BE EXCITED AS WELL AND BE RESPONSIVE. >>IF I MAY ADD ONE THING YOU MAY RECALL AND SEEN IN THE LISTING THAT THESE ARE MULTI-YEAR PROJECTS WHICH IS EXCITING. TO THINK ABOUT HOW WE WANT TO SUSTAIN THESE EFFORTS. THIS IS JUST THE BEGINNING AND WE WANT TO MAKE SURE THIS WAS AN OPPORTUNITY FIRST STEP. SO WE WANT TO CONTINUE THAT FORWARD AND ENSURE THAT THIS IS SOMETHING THAT WE WILL CONTINUE FOR YEARS TO COME. WE'RE EXCITED AND HOPE YOU ARE ALL AS WELL. >>ONE OTHER THING THAT I WILL MENTION AND WE CAN DROP THIS IN THE CHAT IS NIDA HAS RECENTLY RELEASED -- ITS STRATEGIC PLAN FOR 2022-2026. AND I THINK THAT TAKING A LOOK AT THE STRATEGIC PLAN MAY HELP TO GUIDE SOME THOUGHTS ABOUT WHERE WE WOULD LIKE TO BE MOVING IN THE FUTURE. AND HOW I THINK IT MAY BE USEFUL TO THINK ABOUT THE WORK THAT YOU'RE PROPOSING IN THE CONTEXT OF THE STRATEGIC PLAN. CERTAINLY DON'T FEEL LIMITED BY IT. BUT CERTAINLY TAKE A LOOK. AND AT LEAST BE INFORMED BY IT AS YOU THINK ABOUT WHAT YOU WOULD LIKE TO PROPOSE. >>GREAT. THANK YOU FOR ALL OF THE COMMENTS. DR. PARIYADATH I HAVE ANOTHER QUESTION FROM YOU. CAN YOU PLEASE EXPLAIN THE R33 MECHANISM MORE. I'M FAMILIAR WITH THAT FUNDING THE STRUCTURE. IT'S A LESS COMMON ONE AT NIDA. >>SURE. SO THE R61/R33 IS A FACED MECHANISM. IT'S INTENDED TO FUND EXPLORATORY RESEARCH. SO, IT'S SIMILAR TO THE R21 MECHANISM THAT IS MORE COMMON. THE BUDGET IS MUCH HIGHER THAN IN R21. IN THE CASE OF R61 HERE THE BUDGET CAP IS 500,000 FOR DIRECT COSTS SPLIT ACROSS THOSE FIRST TWO YEARS OF THE PROJECT. SO YOU DO HAVE TO PROVIDE MILESTONES FOR THE R61 PHASE AND THE IDEA IS THAT SHOULD YOU MEET THOSE MILESTONES IT INCREASES THE LIKELIHOOD OF TRANSITIONS TO THE R33 PHASE WHERE THE BUDGET INCREASES AGAIN. SO THE POINT IS TO ALLOW THE R61 TO DEVELOP PILOT DATA ON THE EXPLORATORY PART OF THE PROJECT AND USE THAT TOWARDS THE LARGER NOW MORE DEVELOPED PROJECT IN THE R33 PHASE. IF YOU'RE INTERESTED I'M HAPPY TO TALK FURTHER AND WE CAN DISCUSS MORE ABOUT THIS. >>SO WE'RE WAITING FOR QUESTIONS TO COME IN. AND THANK YOU FOR THAT RESPONSE AS WELL. WE DO HAVE A QUESTION THAT JUST CAME IN. AND IF YOU NEEDED TO PARTNER WITH AN INSTITUTION HOW WOULD YOU GO ABOUT DOING THAT? WHAT WOULD BE NEEDED TO ENGAGE THEM? I ENGAGED A UNIVERSITY LARGER SCHOOL. I WAS TOLD I NEEDED MORE TO HAVE THEM INVOLVED OR IT WAS NOT INNOVATIVE ENOUGH. THIS IS MORE OF GETTING INPUT FROM YOU ALL THROUGH YOUR EXPERIENCES AND WORKING WITH DIFFERENT GRANTEES. AND HELPING THEM AND HOW TO ENGAGE OTHERS TO BE A PART OF THIS RESEARCH. >>SO I'LL GET IT STARTED. AND I WOULD LOVE FOR MY COLLEAGUES TO JOIN IN AS WELL. I THINK ONE RESOURCE THAT MANY FOLKS ARE NOT AWARE OF IS THE NIH REPORTER. I THINK IT'S REALLY USEFUL TO DO SOME SEARCHES AND SEE WHO HAS EXPERIENCE WITH AND BY THE WAY LET ME TAKE A STEP BACK. AND SAY NIH REPORTER IS A TOOL THAT CAN BE USED TO SEARCH FOR FUNDED RESEARCH PROJECTS SUPPORTED BY NIH. AND THE THING THAT IS NICE ABOUT IT IS YOU CAN SEE WHO IS DOING WORK THAT ALIGNS VERY NICELY WITH YOUR INTEREST ARE OR WHAT YOUR COMMUNITY WOULD LIKE TO SEE DONE AND YOU CAN SEE WHERE THEY ARE PHYSICALLY. IN THE STATES -- THERE IN THE STATES. AND YOU CAN THINK ABOUT WHAT COMMONALITIES YOU HAVE IN TERMS OF YOUR WORLD VIEW OR YOUR ORIENTATION WITH THAT PARTICULAR WORK. YOU CAN READ THEIR ABSTRACTS. YOU CAN REACH OUT TO THOSE INVESTIGATORS WHO MAY HAVE SOME COMMON GROUND WITH YOU. AND START A CONVERSATION. I FOUND THAT MORE TIMES THAN NOT RESEARCHERS ARE OFTEN WILLING TO HAVE THOSE DISCUSSIONS. AND TO GET CONNECTED WITH FOLKS WHO ARE IN THE COMMUNITY BECAUSE THEIR WORK HAS A MISSION AS WELL. RIGHT? THEY ARE NOT MORE TIMES THAN NOT THEY ARE NOT DOING THIS JUST FOR THE SAKE OF DOING IT. THE WORK THAT WE DO SUPPORTS PUBLIC HEALTH. IT SUPPORTS THE WELL-BEING OF OUR NATION. SO THAT WOULD BE ONE RECOMMENDATION THAT I WOULD MAKE. >>AND I WOULD ADD YOU'RE CERTAINLY WELCOME TO REACH OUT TO ONE OF US AND MORE THAN WELCOMED AND I WOULD ENCOURAGE YOU TO DO SO TO SEE IF WE HAVE ANY IDEAS FOR YOU. WE DON'T ALWAYS BECAUSE WHAT YOUR ARE INTERESTED IN STUDYING MAY BE SOMETHING THAT WE DON'T KNOW MUCH ABOUT BUT WE'RE HERE TO BE RESPONSIVE IF YOU WANT TO REACH OUT. >>DR. CRUMP WE HAVE ANOTHER QUESTION ABOUT THE DP1. HOW DOES CURRENT AND PENDING SUPPORT INFLUENCE FUNDING DECISIONS FOR THE DP1? >>THAT IS A GREAT QUESTION. I'M SO GLAD YOU ASKED THAT. AND I'M JUST GUESSING AND CORRECT ME IF I'M WRONG. I'M GUESSING A PART OF THAT MIGHT HAVE BEEN DRIVEN BY THE FACT THAT SOMETIMES THE DP AWARDS ARE FOR NEW INVESTIGATORS AND THE EXPECTATION IS THAT YOU HAVE NOT NECESSARILY HAD PRIOR AWARDS. THE DP1 IS DIFFERENT. IT DOES NOT REQUIRE THAT YOU HAVE NOT HAD PRIOR NIH FUNDING. THE WAY THAT WE HAVE WRITTEN THE DP1 IT ALSO DOES NOT REQUIRE THAT YOU ARE AN ESTABLISHED NIH INVESTIGATOR. SO WE WOULD LIKE THAT TO NOT BE A BARRIER FOR APPLICANTS. WE WOULD LIKE FOR YOU TO BE ABLE TO SUBMIT WITH YOUR BEST IDEA YOUR BEST SCIENCE AND YOUR EXPERIENCE. YOU HAVE FOLKS WHO WE EXPECT TO SUBMIT FOR THE DP1 HAVE A SET OF STILLS THAT INVOLVE WORKING WITH COMMUNITIES AS WELL AS INVOLVE KNOWING THE SCIENCE AND SO -- THAT IS VERY UNIQUE AND WE DON'T WANT TO PUT ANY MORE BARRIERS AROUND THAT. SO I'M HOPING THAT ANSWERED THE QUESTION. I'LL TAKE IT ANOTHER STEP AND SAY I DON'T WANT TO PROJECT THAT WE WOULD PREFER ONE APPLICANT OVER ANOTHER BECAUSE OF A GRANT HISTORY. I EXPECT THAT AS WE EVALUATE THESE APPLICANTS THESE APPLICATIONS IT'S GOING TO BE ABOUT WHO HAS GOT THE MOST INNOVATIVE VISIONARY IDEAS. . >>SO -- DR. ETZ, WE HAVE A QUESTION HERE ABOUT THE COMMUNITY ENGAGED RESEARCH PROJECTS. SO THIS SAYS -- I'M EXCITED ABOUT THE OPPORTUNITY FOR MORE COMMUNITY ENGAGED RESEARCH. ONE HESITATION IS HOW TO APPROPRIATELY PILOT NEW PROGRAMS OR SERVICES THAT REQUIRE FUNDING AND ENSURE THAT SUCH PROGRAMS CAN BE SUSTAINABLE AFTER THE AWARD PERIOD? WHAT RECOMMENDATIONS OR RESOURCES ARE AVAILABLE FOR RESEARCHERS TO PLAN FOR FINANCIAL ASSISTING ABILITY WITH LOCAL COLLABORATORS TO AVOID POTENTIAL RESEARCH COLONIALISM. >>THAT IS A FANTASTIC QUESTION AND ALSO I THINK SOMETHING THAT CHALLENGES US ALL. SO I'M GOING TO CALL ON DR. DR. CRUMP AND ANYBODY ELSE TO JUMP IN. I THINK A COUPLE OF DIFFERENT WAYS YOU CAN DO IT. ONE IS YOU THINK ABOUT FUNDING AVAILABLE FOR A FULL PROGRAM AND THAT BEING SOMETIMES VERY -- EXPENSIVE. WE CAN LOOK AT DELIVERY ORGANIZATIONS WITHIN THE GOVERNMENT AND THINK ABOUT CONSTRUCTING SOMETHING THAT IS VIABLE UNDER ONE OF THE EXISTING INITIATIVES BUT THERE ARE OTHER WAYS. ONE IS WHO'S DELIVERING THE INTERVENTION? WHO'S BEING TRAINED? PEOPLE WHO WORK WITHIN THE SYSTEM ALREADY? AND SO CAN SOME OF THE SUSTAINABILITY COME FROM THE NEW RESOURCES AND TRAINING THAT IS AVAILABLE FOR STAFF PEOPLE AND I THINK TURN OVER CAN BE AN ISSUE SO, THAT IS NOT A PERFECT SOLUTION BUT ONE WAY TO THINK ABOUT IT. ANOTHER THING IS INCLUDING AN ECONOMIC EVALUATION OF THE PROGRAM. SO THAT AS YOU LOOK FOR OTHER WAYS TO FUND THIS AND WAYS TO SORT OF HAND IT OFF -- THAT YOU HAVE A REALLY GOOD SENSE OF HOW MUCH THIS COSTS. WHAT IS THE COST BENEFIT RATIO. HOW CAN WE CONVINCE PEOPLE TO CONTINUE TO FUND THIS? AND THE OTHER THING IS THINKING ABOUT INTERVENTION IN WAYS THAT IT'S FEASIBLE AND MANAGEABLE. RIGHT? SO NOT ALWAYS BUILDING OUT THE MOST COMPLEX INTERVENTION BUT SOMETHING THAT DOES CONSIDER WHAT IS THE ABSOLUTE DOLLAR AMOUNT THAT IS GOING TO BE NEEDED TO KEEP THIS PROGRAM GOING. AND WOULD THAT BE WITHIN THE BUDGET OF SOME OF THE ORGANIZATIONS THAT WOULD BE ULTIMATELY WORKING TO SUSTAIN THE INTERVENTION. BUT I WOULD LIKE TO INVITE OTHERS TO ADD ANYTHING ELSE THERE. >>SO THANK YOU SO MUCH, DR. ETZ. THAT WAS EXCELLENT AS A RESPONSE. THERE ARE A COUPLE OF ADDITIONAL THOUGHTS. WE STRONGLY ADVISE WHEN POSSIBLE THAT APPLICANTS WORK WITH PARTICULARLY IF YOU'RE TALKING ABOUT PROGRAMS TESTING PROGRAMS THAT YOU WORK WITH INDIVIDUALS WHO ARE IN THE COMMUNITIES, INVOLVED IN THE SERVICE DELIVERY. ONE, BECAUSE THAT HELPS TO MAKE SURE THAT THE PROGRAMMING IS FEASIBLE AND THAT ACTUALLY WORKS FOR THE COMMUNITY. 7 NATURALLY THAT IS A MAJOR PART OF THE COMMUNITY RESEARCH FAO BUT IT'S SOMETHING TO THINK ABOUT GENERALLY. BUT ALSO THERE IS THE NEED WE KNOW FOR SERVICES RESEARCH. SO THERE IS THE NEED FOR RESEARCH TO UNDERSTAND HOW TO TAKE PROGRAMS TO SCALE AND HOW TO TAKE INTERVENTIONS TO SCALE. THAT IS INNOVATIVE IN AND OF ITSELF AND DR. ETZ ALSO REFERENCED THE FACT THAT WE LOOK TO DO WHEN WE CAN ECONOMIC ANALYSES AND UNDERSTAND HOW MUCH IS IT GOING TO COST? HOW MUCH TIME IS IT GOING TO TAKE TO TRAIN PERSONNEL? THERE ARE A LOT OF QUESTIONS THAT CAN BE RESEARCH QUESTIONS BUT IMPORTANTLY OUR MISSION AS -- IS A RESEARCH MISSION AT NIH. SO, IT'S KEY THAT IT HELPS SO MUCH TO BE WORKING WITH AND COGNIZANT OF GROUPS AND INSTITUTIONS THAT HAVE THE SERVICE -- SERVICES FUNDS. SO THAT MAYBE SAMHSA. THAT MAY IS HRSA. IT MAY BE YOUR STATE GOVERNMENT. THERE ARE FUNDS THAT GET FREED UP THROUGH LEGAL SETTLEMENTS FOR EXAMPLE. THE GOVERNMENTS NEED TO FIGURE OUT HOW TO USE. IF YOU HAVE CONNECTIONS RIGHT, THERE IS THE POTENTIAL FOR THINKING ABOUT DOWN THE ROAD WHERE THERE IS SOME REVENUE STREAMS TO SUPPORT THE INTERVENTION RESEARCH. SORRY, THE INTERVENTION SERVICES, MY FAULT. THIS IS A REALLY CRITICAL QUESTION THAT IS NOT AN EASY QUESTION. ONE THAT THOSE OF US WHO ARE IN RESEARCH HAVE BEEN STRUGGLING WITH FOR QUITE A WHILE BECAUSE THERE IS NOT A VERY SIMPLE FUNDING STREAM A LOT OF TIMES >>AND I WOULD INVITE ANYONE ELSE TO OFFER COMMENTS -- THIS IS A REALLY PRICKLY ISSUE. >>THANK YOU FOR THAT AND THAT IS EVERYONE THAT COMMENTED ON THAT QUESTION. WE ARE STILL WAITING FOR QUESTIONS TO COME IN TO THE BOX. AND IN THE MEANTIME -- IF ANYONE HAS ANY OTHER REMARKS THAT THEY WOULD LIKE TO SHARE WHILE WE'RE WAITING FOR QUESTIONS TO COME THROUGH PLEASE DO SO. GREAT. WE HAVE A QUESTION THAT JUST CAME IN. AND IT'S -- THERE IS A PRIORITY TO FUND PI REPRESENTATIVE OF RACIAL ETHNIC MINORITY POPULATIONS? IS THERE A PRIORITY? >>WILL, WOULD YOU LIKE TO TAKE THAT? >>SURE. I HAVE TO FIND THE UNMUTE BUTTON FIRST. ABSOLUTELY. PART OF IT IS INCREASING OUR DIVERSITY OF THE WORKFORCE AND THAT IS ONE OF THE PILLARS OF REI. SO I DIDN'T SPEND A LOT OF TIME DISCUSSING THAT BUT THAT IS ABSOLUTELY ONE OF THE STRONGEST PILLARS OF REI IS TO INCREASE THE DIVERSITY OF OUR WORKFORCE. SO WE'RE EXTREMELY EXCITED AND WORKING TO ESTABLISH OTHER MECHANISMS THAT INCLUDE F AWARDS AND OTHER AWARDS AS WELL. SO IT'S AN EXCITING TIME AND WE WANT TO INCREASE OUR DIVERSITY. IMPORTANT QUESTIONS ARE ASKED AND IMPORTANT RESEARCH IS ENGAGED WHEN YOU HAVE DIVERSITY SO, THAT IS AN AREA THAT WE'RE STRONGLY FOCUSED ON. SO THANK YOU FOR THAT QUESTION. >>OKAY. IT LOOKS LIKE WE DON'T HAVE ANY MORE QUESTIONS IN THE Q&A BOX. SO I'LL TURN IT OVER TO THE PANELISTS TO SAY ANY FINAL COMMENTS THAT THEY WOULD LIKE TO SAY FOR THIS WEBINAR THIS AFTERNOON. >>OKAY. BEFORE I CLOSE THINGS OUT ANY FINAL REMARKS? >>ARIA, I CAN SAY THAT HOPEFULLY WE'VE IMPRESSED UPON YOU THAT WE'RE EAGER TO ANSWER YOUR QUESTIONS AND SUPPORT YOU IN APPLYING TO THESE FUNDING OPPORTUNITY ANNOUNCEMENTS SO PLEASE DO NOT HESITATE TO REACH OUT TO US. EITHER TO UNDERSTAND HOW TO APPLY FOR THIS OR PROVIDE ANY OTHER FEEDBACK THAT YOU THINK WOULD BE HELPFUL TO ENSURE THAT WE DO THE BEST JOB THAT WE CAN DO TO ADDRESS THESE DISPARITIES. SO THANKS VERY MUCH. >>AND I'LL QUICKLY ADD TO THOSE WHO HAD QUESTIONS WHO ARE FROM COMMUNITY ORGANIZATIONS ABOUT HOW TO INCREASE PARTNERSHIPS WITH INSTITUTIONS FOR THESE FUNDING ANNOUNCEMENTS SO IT'S IMPORTANT TO REMEMBER THAT ALL OF THESE ANNOUNCEMENTS ARE COMMUNITY ENGAGEMENT IS REQUIRED. SO FOR ALL OF THESE ANNOUNCEMENTS. SO WHEN YOU'RE TALKING TO ORGANIZATIONS OR INSTITUTIONS IT'S IMPORTANT TO REMIND THEM OF THAT. AND TO SHOW THEM THIS INFORMATION BECAUSE A LOT OF THEM WILL BE LOOKING FOR PARTNERS. THEY WILL BE LOOKING FOR YOU WHEN YOU CAN REACH OUT TO THEM. A BENEFICIAL RELATIONSHIP. MAKE SURE THAT THE INSTITUTION KNOWS THAT THERE IS AMAZING OPPORTUNITIES BUT THEY REQUIRE COMMUNITY ENGAGEMENT AND BETWEEN OUR EXPERTISE AND EXPERIENCE AND EXPERIENCE IN THE FIELD WE CAN DO SOME INCREDIBLE WORK. SO, THAT IS ANOTHER WAY TO START TO BUILD THE PARTNERSHIPS AND MAKE SURE YOU HAVE EVERYONE THAT IS NEEDED IN ORDER TO QUALIFY. BUT REMEMBER THAT PARTNERSHIP IS WHAT -- IS ESSENTIAL. SO I LOOK FORWARD TO WORKING WITH ANYBODY WHO HAS QUESTIONS. SO FEEL FREE TO REACH OUT TO US AND THANK YOU FOR ATTENDING AND FOR YOUR QUESTIONS. >>OKAY. SO, I'LL WRAP THINGS UP. PLEASE, PLEASE DO I WANT TO ECCO MY * COLLEAGUES IN SAYING WE'RE VERY MUCH LOOKING FORWARD TO SPEAKING WITH YOU AND LEARNING WHAT YOUR IDEAS ARE AND TAKING ADVANTAGE OF THIS OPPORTUNITY TO INVEST IN TRANSFORMATIVE RESEARCH AND RESEARCH THAT IS GOING TO MAKE A DIFFERENCE IN THE LIVES OF PEOPLE ACROSS THIS COUNTRY. 7 AND SO PLEASE DO FEEL FREE TO CONTACT US. NOTE THAT RECORDING OF TODAY'S WEBINAR IS GOING TO BE AVAILABLE ON THE NIH VIDEO CAST WEBSITE. AND DO FEEL FREE TO REACH OUT TO ONE OF THE CONTACTS AND PART TWO SECTION 7 OF THE RFA. I WANT TO THANK NIDA LEADERSHIP AND ALL OF MY COLLEAGUES WHO HAVE DEDICATED SIGNIFICANT TIME TO THESE EFFORTS. AND THANK YOU ALL FOR JOINING THIS SESSION TODAY FOR TAKING TIME OUT OF YOUR DAY TO LEARN MORE ABOUT THE RFAs AND WE LOOK FORWARD TO RECEIVING YOUR APPLICATIONS. HAVE A GOOD DAY.